Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586937 · ClinicalTrials.gov registry record
Quality of Life in Lung Cancer Survivors
A clinical trial of Lung Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 193
- Enrollment target
- 1
- Study location
NCT00586937: Completed study of Lung Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00586937 is a study of Lung Cancer Survivors that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 193 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00586937, a study of Lung Cancer Survivors, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 193 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.
Conditions Studied
Interventions
- BEHAVIORAL questionnaires or telephone interview
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2005-06 |
| Est. Completion | 2020-01-02 |
What the finished NCT00586937 record still lists
NCT00586937 is an observational study that tracks outcomes without assigning an intervention. The registered 193 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Lung Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which questionnaires or telephone interview is the first listed.
NCT00586937 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00586937 about?
NCT00586937 is a clinical study titled "Quality of Life in Lung Cancer Survivors". The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, ...
What is the current status of trial NCT00586937?
This trial is currently completed. The enrollment target is 193 participants. The study started on 2005-06. Estimated completion is 2020-01-02.
What conditions does trial NCT00586937 study?
This clinical trial studies the following conditions: Lung Cancer Survivors.
What interventions are being tested in trial NCT00586937?
The interventions under investigation include: questionnaires or telephone interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00586937?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00586937 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06226220 · 193 participants · NA
Percutaneous Nerve Evaluation Trial Time
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia